Al-Nahrain University Academic Staff Profiles System

Academic staff profiles
Al-Nahrain University

عربي | English

PERSONAL INFORMATION

Full Name: Dr. Feryal Hashim Rada Gender: Female Birthdate: 1971 Nationality: Iraq Degree: PhD Academic Title: Professor College\Center: College of Pharmacy Departement: Pharmacy Major: Pharmacy Specialty: Clinical chemistry and therapeutics Mother Language: Arabic Other Languages: English Work email: dr.feryal.hashim@ced.nahrainuniv.edu.iq Personal email: fermsc33@yahoo.com

Publications

Impact of Osteoprotegerin and RANKL on Non-ST-segment Elevation Myocardial Infarction
F Rada, 2021
International Journal of Nutrition, Pharmacology, Neurological Diseases, 11, (3), 206-210
Platelets Prohibition with Clopidogrel Alone versus with Proton‑Pump Inhibitors
F Rada, 2021
Biomedical and Biotechnology Research Journal, 5, (3), 327-330

Adequacy of Olmesartan monotherapy versus cotherapy in patients with essential hypertension
F Rada, 2020
International Journal of Research in Pharmaceutical Sciences, 11, (2), 1649-1654
Effect of Angiotensin II Receptor Blocker Treatment on Adipokine of Corpulence
F Rada, 2020
Biomedical and Pharmacology Journal, 13, (2), 957-963
Platelet reactivity with a third generation thienopyridine drug versus with a second-generation thienopyridine drug
F Rada, 2020
International Journal of Research in Pharmaceutical Sciences, 11, (3), 3704-3709

PEROXISOME PROLIFERATOR- ACTIVATED RECEPTORS FAMILY OVERVIEW
F Rada, 2019
EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH, 6, (1), 167-170

OXIDATIVE STRESS ASSESSMENT IN PATIENTS WITH DIABETIC NEPHROPATHY
F Rada, 2018
EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH, 5, (1), 44-47
OXIDATIVE STRESS AND SOME INFLAMMATORY BIOMARKERS IN PATIENTS WITH CORONARY HEART DISEASE
F Rada, 2018
EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH, 5, (1), 9-12
Genetic Analysis
F Rada, 2018
EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH, 5, (10), 95-98
ANTIPLATELET ADEQUACY OF CYCLOPENTYL TRIAZOLOPYRIMIDINE VERSUS CLOPIDOGREL IN-PATIENTS WITH CORONARY HEART DISEASE
F Rada, 2018
asian journal of pharmaceutical and clinical research, 11, (12), 536-539

ASSESSMENT OF PYRAZINO-PYRIMIDINE COMPOUND AND SOME INFLAMMATORY BIOMARKERS IN PATIENTS WITH TYPE 2 DIABETES
F Rada, 2017
international journal of pharmaceutical sciences and research, 8, (6), 2691-2695
ASSOCIATION OF LIPID FRACTIONS LEVELS WITH CARDIOVASCULAR DISEASE
F Rada, 2017
asian journal of pharmaceutical and clinical research, 10, (3), 180-183

FETUIN-A IN PATIENTS WITH KIDNEY DISEASE
F Rada, 2016
World Journal of Pharmaceutical Research, 5, (1), 240-247
CLOPIDOGREL AND LIVER INJURY IN DIABETIC PATIENTS
F Rada, 2016
EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH, 3, (6), 168-170
Efficacy of Octreotide acetate on acromegalic patients
F Rada, 2016
EUROPEAN JOURNAL OF PHARMACEUTICAL AND MEDICAL RESEARCH, 3, (12), 31-33
FENOFIBRATE ADVERSE EFFECTS VERSUS ATORVASTATIN
F Rada, 2016
international journal of research in pharmacy and chemistry, 6, (1), 32-37

CYSTATIN C IN DIABETIC PATIENTS
F Rada, 2015
international journal of research in pharmacy and chemistry, 5, (2), 274-278
Hepatotoxicity of Combined Therapy of Atorvastatin with Platelet P2Y12-ADP Receptor Antagonist in Coronary Heart Disease Treated Patients
F Rada, N Hasan, M Bagh, 2015
the iraqi postgraduat medical journal, 14, (1), 108-113

ASSESSMENT OF ADVERSE EFFECT OF ATORVASTATIN WITH PLATELET P2Y12-ADP RECEPTOR ANTAGONIST ON PLATELETS AGGREGATION AND RENAL FUNCTION IN CORONARY HEART DISEASE TREATED PATIENTS
F Rada, N Hasan, M Baghdadi, 2014
international journal of research in pharmacy and chemistry, 4, (2), 274-282

Leptin in Goitrous patients
, F Rada, N Al-Sakkal, A Yahia, 2009
mustansiriya medical journal, 8, (1), 33-35

620 Profile visits - Profile last updated on: 2023-07-07 14:08:13

2021

2020

2019

2018

2017

2016

2015

2014

2009